US Broker Ratings

Cencora, Inc. (COR) Stock Analysis: Exploring a Strong Return on Equity and Growth Prospects in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a leading player in the healthcare sector, has been capturing investor interest thanks to its robust financial performance and strategic positioning in..

Solventum Corporation (SOLV) Stock Analysis: Navigating Healthcare Innovation with a Strong 37.27% ROE

Solventum Corporation (NYSE: SOLV), a burgeoning player in the healthcare sector, is capturing investor attention with its innovative portfolio and robust financial performance. The company, with..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking the 19.87% Potential Upside in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a pioneering name in the biotechnology sector, stands out with its innovative approach to muscle activators and inhibitors, targeting debilitating diseases with..

Teva Pharmaceutical Industries (TEVA): Investor Outlook on a Potential 15.23% Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent name in the healthcare sector, stands as a global leader in the production and distribution of generic and..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Deep Look Into Its 38.61% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is capturing investor attention with its significant potential upside of 38.61%. Based in Morrisville,..

Madrigal Pharmaceuticals (MDGL) Investor Outlook: Navigating Biotech Upside with 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has been capturing attention in the biotechnology sector with its impressive financial trajectory and innovative approach to treating metabolic dysfunction-associated steatohepatitis..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Healthcare Giant with a 21.71% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable name in the pharmaceutical industry, offers a promising opportunity for investors seeking exposure to the healthcare sector. With..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating Growth and Investor Ratings in the Healthcare Sector

HCA Healthcare, Inc. (HCA) stands as a formidable player in the healthcare sector, a fact underscored by its substantial market capitalization of $114.89 billion. This American..

Prestige Consumer Healthcare Inc. (PBH): Investor Outlook Reveals 31% Potential Upside Amid Robust Analyst Support

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the over-the-counter (OTC) healthcare space, has caught the attention of investors with a compelling growth narrative..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unpacking a 44.98% Potential Upside for Investors

For investors keen on healthcare stocks, Lantheus Holdings, Inc. (NASDAQ: LNTH) presents an intriguing proposition. With its diverse portfolio in diagnostic and therapeutic products, Lantheus is..

Waters Corporation (WAT) Stock Analysis: Navigating Market Dynamics with Strong Revenue Growth and Strategic Positioning

Waters Corporation (NYSE: WAT), a stalwart in the Healthcare sector and a leader in the Diagnostics & Research industry, offers intriguing opportunities for investors despite current..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Unveiling a 4.44% Growth Potential in the Healthcare Sector

Thermo Fisher Scientific Inc. (NYSE: TMO) stands as a formidable entity within the healthcare sector, particularly in the diagnostics and research industry. With a robust market..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 20.82% Potential Upside in Medical Devices

Integer Holdings Corporation (NYSE: ITGR) operates at the nexus of the healthcare and medical devices industries, serving as a critical partner to multi-national original equipment manufacturers...

Amgen Inc. (AMGN) Stock Analysis: Impressive Dividend Yield Amidst Conservative Growth Outlook

For individual investors eyeing opportunities in the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling case. As a titan in the drug manufacturing industry, Amgen..

Ascendis Pharma A/S (ASND) Stock Analysis: 21.62% Potential Upside with Strong Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of investors with its impressive growth trajectory and robust analyst support, offering a potential upside of 21.62%...

Biogen Inc. (BIIB) Stock Analysis: Navigating Potential Upside Amid Sector Dynamics

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to intrigue investors with its focus on neurological and neurodegenerative diseases. With a market capitalization..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating Challenges in the Healthcare Sector

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, has been navigating a complex landscape marked by both opportunities and challenges. As..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Potential Upside of Over 24% Amid Robust Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on developing treatments for rare neuroendocrine diseases. With a current market capitalization..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: 20% Potential Upside Ignites Investor Interest

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a leading player in the biopharmaceutical sector specializing in therapies for central nervous system (CNS) disorders, has captured the attention of..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring Growth Potential with an 18 Buy Rating Consensus

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a titan in the biotechnology sector, continues to capture investor interest with its robust portfolio of innovative treatments and promising collaborations...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds